1t5q
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:1t5q.gif|left|200px]] | + | [[Image:1t5q.gif|left|200px]] |
| - | + | ||
| - | '''Solution Structure of GIP(1-30)amide in TFE/Water''' | + | {{Structure |
| + | |PDB= 1t5q |SIZE=350|CAPTION= <scene name='initialview01'>1t5q</scene> | ||
| + | |SITE= | ||
| + | |LIGAND= | ||
| + | |ACTIVITY= | ||
| + | |GENE= | ||
| + | }} | ||
| + | |||
| + | '''Solution Structure of GIP(1-30)amide in TFE/Water''' | ||
| + | |||
==Overview== | ==Overview== | ||
| Line 10: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1T5Q is a [ | + | 1T5Q is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1T5Q OCA]. |
==Reference== | ==Reference== | ||
| - | NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide., Alana I, Hewage CM, Malthouse JP, Parker JC, Gault VA, O'Harte FP, Biochem Biophys Res Commun. 2004 Dec 3;325(1):281-6. PMID:[http:// | + | NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide., Alana I, Hewage CM, Malthouse JP, Parker JC, Gault VA, O'Harte FP, Biochem Biophys Res Commun. 2004 Dec 3;325(1):281-6. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15522230 15522230] |
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Alana, I.]] | [[Category: Alana, I.]] | ||
| Line 28: | Line 37: | ||
[[Category: obesity]] | [[Category: obesity]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 14:14:11 2008'' |
Revision as of 12:14, 20 March 2008
| |||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Solution Structure of GIP(1-30)amide in TFE/Water
Contents |
Overview
Glucose-dependent insulinotropic polypeptide is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions. The glucose-dependent action of GIP on pancreatic beta-cells has attracted attention towards its exploitation as a potential drug for type 2 diabetes. Use of NMR or X-ray crystallography is vital to determine the three-dimensional structure of the peptide. Therefore, to understand the basic structural requirements for the biological activity of GIP, the solution structure of the major biologically active fragment, GIP(1-30)amide, was investigated by proton NMR spectroscopy and molecular modelling. The structure is characterised by a full length alpha-helical conformation between residues F(6) and A(28). This structural information could play an important role in the design of therapeutic agents based upon GIP receptor agonists.
Disease
Known diseases associated with this structure: Pituitary ACTH-secreting adenoma OMIM:[139360], Ventricular tachycardia, idiopathic OMIM:[139360]
About this Structure
1T5Q is a Single protein structure of sequence from [1]. Full crystallographic information is available from OCA.
Reference
NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide., Alana I, Hewage CM, Malthouse JP, Parker JC, Gault VA, O'Harte FP, Biochem Biophys Res Commun. 2004 Dec 3;325(1):281-6. PMID:15522230
Page seeded by OCA on Thu Mar 20 14:14:11 2008
Categories: Single protein | Alana, I. | Gault, V A. | Harte, F P.M O. | Hewage, C M. | Malthouse, J P.G. | Parker, J C. | Diabetes | Gip | Helix | Molecular modelling | Nmr | Obesity
